4th Quarter - Report
BROWN RUDNICK LLP for PRIME THERAPEUTICS
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to generic pharmaceutical utilization and prescription drug abuse under the Medicare Part D prescription drug program. Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04) |
Pharmacy PHA
HR 4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen. Stabenow (05-07) |
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.